Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Azelis Group NV's EPS (Basic) for the
six
months ended in Jun. 2026 was €0.35.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was €0.47.
During the past 12 months, Azelis Group NV's average EPS without NRIGrowth Rate was -27.30% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -22.10% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 14.20% per year.
During the past 8 years, Azelis Group NV's highest 3-Year average EPS without NRI Growth Rate was 64.70% per year. The lowest was -22.10% per year. And the median was 37.10% per year.
Azelis Group NV (FRA:2R7) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Azelis Group NV Earnings per Share (Diluted) Related Terms
Azelis Group NV Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Azelis Group NV's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azelis Group NV Earnings per Share (Diluted) Chart
FRA:2R7 vs LIN, SHW, ECL: Earnings per Share (Diluted) Comparison
For the Specialty Chemicals subindustry, Azelis Group NV's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azelis Group NV PE Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Azelis Group NV's PE Ratio distribution charts can be found below:
* The bar in red indicates where Azelis Group NV's PE Ratio falls into.
Azelis Group NV Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Azelis Group NV's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of €0.47 mean?
Azelis Group NV (FRA:2R7) has a Earnings per Share (Diluted) of €0.47 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Azelis Group NV and its competitors. According to the industry distribution chart, Azelis Group NV ranks #960 out of 1255 companies in the Chemicals industry, placing it in the top 76.5%.
Is Azelis Group NV's Earnings per Share (Diluted) too high?
Azelis Group NV's current Earnings per Share (Diluted) is €0.47. Based on the distribution chart, Azelis Group NV ranks #960 out of 1255 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Azelis Group NV has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azelis Group NV's Earnings per Share (Diluted) compare to LIN and SHW?
According to the Chemicals industry distribution chart, Azelis Group NV ranks #960 out of 1255 companies for Earnings per Share (Diluted). This places Azelis Group NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Chemicals company?
A good Earnings per Share (Diluted) depends on the Chemicals industry context. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Azelis Group NV and its competitors. Azelis Group NV's current Earnings per Share (Diluted) is €0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azelis Group NV stock overvalued right now?
Based on GuruFocus' analysis, Azelis Group NV (FRA:2R7) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.22, compared to a current price of €12.31 — trading 28.5% below its estimated fair value. The current Earnings per Share (Diluted) is €0.47. Azelis Group NV's overall GF Score™ is 77/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Azelis Group NV (FRA:2R7), the current Earnings per Share (Diluted) is €0.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azelis Group NV (FRA:2R7) Overvalued in 2026?
Based on GuruFocus' analysis, Azelis Group NV stock appears to be undervalued.
The current stock price of €12.31 is trading 28.5% below its estimated GF Value™ of €17.22.
GuruFocus considers Azelis Group NV to be Modestly Undervalued.
Key valuation signals for FRA:2R7:
Earnings per Share (Diluted): €0.47
GF Value™: €17.22 vs. price of €12.31 (28.5% below fair value)
No single metric tells the full story. See the FRA:2R7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azelis Group NV is an innovation service provider and distributor of speciality chemicals and food ingredients. The Group provides innovation services, multi-product formulations, technical and regulatory expertise, co-creation support, digital solutions, and supply chain services. It serves Food & Nutrition, Animal Nutrition, Personal Care, Home Care & Industrial Cleaning, Pharmaceuticals & Healthcare, Agriculture & Environmental Solutions, Flavours & Fragrances, and Nutraceuticals. The Group operates through four segments: EMEA, Americas, Asia Pacific, and Group holding & other, covering operating companies across Europe, the Middle East and Africa, the United States, Canada, Mexico and South America, Asia, and the Pacific region.
77GF Score
Get the complete analysis for FRA:2R7
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2R7 has been successfully added to your 
